drugset / Trial / NCT01024777

Safety and Immunologic Effect of Low Dose Versus High Dose Vitamin D3 in Multiple Sclerosis

NCT01024777

Phase 1 Completed 40 enrolled Johns Hopkins University
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the safety and the immunologic effects of supplementation with low-dose and high-dose cholecalciferol (vitamin D3) in patients with multiple sclerosis.

Timeline

Start
2010-03
Primary completion
2013-01
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cholecalciferol Other / unclassified 400 iu
Comparator Cholecalciferol Other / unclassified 10000 iu